EVENTS

ACVIM 2024 in Minneapolis, MN | June 6-8, 2024

Attend sessions in cardiology, large animal internal medicine, neurology, nutrition, oncology and small animal internal medicine, PLUS multispecialty topics including business, leadership & communications, education & research, wellbeing and more. Come visit us at booth 1012. (https://www.acvim.org/acvim-forum/2024-acvim-forum)

 

SWVS 2024 in Fort Worth, TX | September 26-29, 2024

Southwest Veterinary Symposium represents innovative partnerships that focus on creating an unparalleled education experience, advancing the entire veterinary profession, and fostering a spirit of reciprocal investment among our partner VMAs, attendees, and exhibitors. Come visit us at booth 413. (https://swvs.org/)

 

2024 Purdue Veterinary Conference | September 17-21, 2024

The conference will commence with the Elanco Human-Animal Bond Lecture on Tuesday, September 17, setting the stage for a week of insightful learning and networking opportunities. (https://vet.purdue.edu/conference/)

 

2024 Purdue Veterinary Conference in Chicago, IL | November 8-11, 2024

The convention features 74 CE sessions including sexual harassment prevention training, three hours of opioid manadates and three hours of CVT utiization CE. (https://www.isvma.org/)

 

PAST EVENTS

VMX 2024 in Orlando, Florida | January 13-17, 2024

Gather with global leaders in veterinary medicine while engaging in world-class education and show-stopping entertainment at VMX 2024. Stop by our booth to learn more about us. (link: https://navc.com/vmx/live/)

Indiana Veterinary Medical Association (IVMA) Crossroads Conference| February 1-3, 2024

The premier conference for veterinarians, technicians, practice managers, and veterinary students. Stop by our booth to learn more about us. https://invma.org/crossroads-veterinary-conference/

 

Midwest Veterinary Conference| February 22-24, 2024

Hosted by the Ohio Veterinary Medical Association, the Midwest Veterinary Conference (MVC) brings together thousands of animal care professionals each year.  https://www.mvcinfo.org/about.html

DVM360

MiraVista Partnered with DVM360 to Sponsor a 1-hr RACE® Approved Course on Antifungal Therapy in Small Animals  

https://ce.dvm360.com/courses/antifungal-therapy-in-small-animals-on-demand

Key Learning Objectives:

  • Treatment of choice for common invasive fungal infections.
  • Monitoring antifungal treatment to avoid adverse effects.
  • Available options for salvage therapy.

VETgirl Podcast: Endemic Mycoses and Treatment

Dr. Hanzlicek presented a podcast on VETgirl, discussing endemic mycoses and treatment. Click the links below to listen to the presentation.

Is There a Fungus Among Us?

Dr. Andrew Hanzlicek presented a 1-hour webinar on VetGirl, discussing clinical review of antifungal treatment recommendations for common invasive fungal infections in dogs and cats, including blastomycosis, histoplasmosis, coccidioidomycosis, cryptococcosis, and opportunistic molds.

Speaker: Dr. Andrew Hanzlicek, Director, Veterinary Medicine & Research

VETgirl Newsletter featuring Dr. Hanzlick’s discussion on Antifungal Therapy: Q1 2021 VETgirl Newsletter (PDF)

Recorded Webinar: March 21, 2021: Antifungal Therapy – Past, Present & Future

Referenced in Webinar: AmBisome® Protocol

Further Reading: Antifungal Therapy – Past, Present & Future (PDF)

NEWS

2023 SPONSORSHIPS

DVM360

Blastomycosis & Histoplasmosis – Efficient Diagnosis, Treatment and Treatment Monitoring (link: https://ce.dvm360.com/courses/blastomycosis-histoplasmosis-efficient-diagnosis-treatment-and-treatment-monitoring-1)

  • CE Credit Hour / Veterinarians & Veterinary Technicians

DVM360
Invasive Fungal Infections NOT Invasive Diagnostic Investigations – Fungal Biomarkers in Cats and Dogs  https://ce.dvm360.com/courses/invasive-fungal-infections-not-invasive-diagnostic-investigations-fungal-biomarkers-in-cats-and-dogs)

1.0 CE Credit Hour / Veterinarians & Veterinary Technicians

Test Report Updates for 2021

In order to maintain good business practices, MiraVista Diagnostics is providing a 90-day notice of pending updates to our referral testing customers.

  • Beginning March 1, 2021 MiraVista Diagnostics will transition to an improved MVista® HistoplasmaAntigen Quantitative EIA.

MiraVista to Receive Economic Incentives from IEDC for Expansion Efforts

Read More

CREDENTIALS: